Amantadine Hydrochloride
NDC 10135-693, Amantadine Hydrochloride, capsule, gelatin coated, from Marlex Pharmaceuticals Inc.
- Product NDC
- 10135-693
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals Inc
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210129
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-693 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMANTADINE HYDROCHLORIDE100 mg/1
Pharmacologic classes
Influenza A M2 Protein Inhibitor [EPC]; M2 Protein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-693-01 | 10135069301 | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (10135-693-01) |
| 10135-693-05 | 10135069305 | 500 CAPSULE, GELATIN COATED in 1 BOTTLE (10135-693-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/25af52ee-9b29-4c07-a383-62d4537b63e0
Use it
Look up 10135-693 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-693 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-693. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.